ES542483A0 - Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral - Google Patents

Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral

Info

Publication number
ES542483A0
ES542483A0 ES542483A ES542483A ES542483A0 ES 542483 A0 ES542483 A0 ES 542483A0 ES 542483 A ES542483 A ES 542483A ES 542483 A ES542483 A ES 542483A ES 542483 A0 ES542483 A0 ES 542483A0
Authority
ES
Spain
Prior art keywords
temperature
phase
preparation
range
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES542483A
Other languages
English (en)
Other versions
ES8607011A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of ES8607011A1 publication Critical patent/ES8607011A1/es
Publication of ES542483A0 publication Critical patent/ES542483A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
ES542483A 1984-03-30 1985-03-29 Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral Expired ES8607011A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8405058A FR2561916B1 (fr) 1984-03-30 1984-03-30 Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau

Publications (2)

Publication Number Publication Date
ES8607011A1 ES8607011A1 (es) 1986-05-16
ES542483A0 true ES542483A0 (es) 1986-05-16

Family

ID=9302670

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542483A Expired ES8607011A1 (es) 1984-03-30 1985-03-29 Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral

Country Status (10)

Country Link
US (1) US4616047A (es)
EP (1) EP0159237B1 (es)
JP (1) JPS60224617A (es)
AT (1) ATE34078T1 (es)
AU (1) AU567271B2 (es)
CA (1) CA1233119A (es)
DE (1) DE3562555D1 (es)
ES (1) ES8607011A1 (es)
FR (1) FR2561916B1 (es)
ZA (1) ZA852168B (es)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
JPS60239417A (ja) * 1984-05-15 1985-11-28 Sankyo Co Ltd エマルシヨン凍結乾燥製剤の製法
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
IL86892A (en) * 1987-07-08 1993-04-04 Lafon Labor Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy
FR2645740B1 (fr) * 1989-04-12 1994-01-28 Fabre Cosmetique Pierre Compositions topiques triphasiques et extemporanement emulsionnables utiles en cosmetologie et/ou dermatologie
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) * 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
JP3074731B2 (ja) * 1989-12-01 2000-08-07 日本新薬株式会社 脂肪乳剤
JP3074732B2 (ja) * 1989-12-01 2000-08-07 日本新薬株式会社 脂肪乳剤
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
WO1992017162A1 (en) * 1991-04-05 1992-10-15 Warner-Lambert Company Lyophilized emulsion
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
EP0663818A4 (en) * 1992-09-03 1996-04-24 Ibah Inc TASTE-COVERING PHARMACEUTICAL SUMMARY AND METHOD FOR PRODUCING THE SAME.
DE4244122C1 (de) * 1992-12-24 1994-06-01 Sanol Arznei Schwarz Gmbh Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
US5382437A (en) * 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
KR0181252B1 (ko) * 1996-12-31 1999-03-20 박원훈 에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
EP1001748B1 (en) * 1997-07-25 2006-04-19 Alpex Pharma S.A. A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
WO2000006124A2 (en) * 1998-07-30 2000-02-10 Point Biomedical Corporation A novel excipient for the lyophilization of aqueous suspensions of microparticles
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
JP2001089398A (ja) * 1999-09-20 2001-04-03 Meiji Seika Kaisha Ltd 経口投与用の凍結乾燥製剤及びその製造方法
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
CA2434504A1 (en) * 2001-01-26 2002-08-01 Teddy Kosoglou Combinations of sterol absorption inhibitor(s) with blood modifiers for treating vascular conditions
RU2003126186A (ru) * 2001-01-26 2005-03-10 Шеринг Корпорейшн (US) Комбинации ингибитора (ингибиторов) всасывания стерина с сердечно-сосудистым агентом (агентами), предназначенные для лечения патологических состояний сосудов
WO2002058685A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
TWI337083B (en) * 2001-01-26 2011-02-11 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
SI1363668T1 (sl) * 2001-01-26 2007-12-31 Schering Corp Kombinacija sekvestranta(-ov) in zaviralca(-ev) absorpcije sterola ter zdravljenje vaskularnih indikacij
US7417039B2 (en) * 2001-01-26 2008-08-26 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
JP5684440B2 (ja) * 2001-02-23 2015-03-11 シーマ・ラブス、インコーポレイテッド 組成物および固形製剤
AU2002308778A1 (en) * 2001-05-25 2002-12-09 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
ATE345793T1 (de) * 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
CN1556700A (zh) * 2001-09-21 2004-12-22 ���鹫˾ 使用甾醇吸收抑制剂治疗或预防脉管炎的方法
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2003030872A2 (en) * 2001-10-12 2003-04-17 Elan Pharma International Ltd. Compositions having a combination of particles for immediate release and for controlled release
EP1941878A1 (en) 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative non-benzodiazepine formulations
AU2003222027A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
US20040092499A1 (en) * 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
ES2365012T3 (es) * 2002-11-12 2011-09-20 Elan Pharma International Limited Formas farmacéuticas sólidas de desintegración rápida que no son friables y que comprenden pululano.
ATE406364T1 (de) * 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
ES2318274T3 (es) 2003-03-07 2009-05-01 Schering Corporation Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1756755A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
US20050096307A1 (en) * 2003-11-05 2005-05-05 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
CA2600669A1 (en) * 2005-03-08 2006-09-14 Nestec S.A. Process for preparing nutritional compositions
DK1910384T3 (da) 2005-08-04 2012-12-17 Sirtris Pharmaceuticals Inc Imidazo [2,1-b] thiazol-derivater som sirtuinmodulerende forbindelser
US9877921B2 (en) 2005-09-09 2018-01-30 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20160045457A1 (en) 2005-09-09 2016-02-18 Ousama Rachid Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
US20080031947A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. Orally dissolvable/disintegrable lyophilized dosage forms containing protected
DE102008015366A1 (de) * 2008-03-20 2009-09-24 Merck Patent Gmbh Lyophilisierte Nanoemulsion
EP2359812A1 (en) * 2010-01-18 2011-08-24 Cephalon France Oral lyophilised compositions
WO2011086194A1 (en) 2010-01-18 2011-07-21 Cephalon France Improved oral lysophilisates containing pvp/va
US20120322884A1 (en) 2010-03-01 2012-12-20 University Of Manitoba Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
MX2013002430A (es) 2010-09-01 2013-07-22 Arena Pharm Inc Formas de dosis de disolucion de rápida de agonistas de 5-ht2c.
TR201007613A2 (tr) * 2010-09-16 2012-04-24 Yed�Tepe �N�Vers�Tes� Liyofilize biyopestisit efervesan granül ve üretim yöntemi
US20120282335A1 (en) 2010-12-02 2012-11-08 Aptalis Pharmatech Inc. Rapidly dispersing granules, orally disintegrating tablets and methods
EP2753321B1 (en) 2011-10-21 2021-12-15 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
CA3169368A1 (en) 2012-06-15 2014-01-09 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
EP3888642A1 (en) 2013-03-22 2021-10-06 Nova Southeastern University Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
SG11202001397VA (en) 2017-09-08 2020-03-30 Insignis Therapeutics Inc Methods of using dipivefrin
EP3930685A1 (en) 2019-03-01 2022-01-05 Insignis Therapeutics, Inc. Dipivefrin orally disintegrating tablet formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520939A (en) * 1947-01-27 1950-09-05 Inst Divi Thomae Foundation Process of concentrating milk
GB806723A (en) * 1955-09-02 1958-12-31 Ici Ltd New pharmaceutical compositions
US3464834A (en) * 1965-06-17 1969-09-02 Grace W R & Co Freeze-drying ice milk confections
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
CH558659A (fr) * 1969-11-26 1975-02-14 Orsymonde Procede pour la preparation d'une composition lyophilisee a usage hygienique.
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1447988A (en) * 1973-04-03 1976-09-02 Orsymonde Pharmaceutical compositions
US4001944A (en) * 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
US3961424A (en) * 1975-08-28 1976-06-08 General Foods Corporation Process for freezing coffee extract prior to lyophilization
JPS5296724A (en) * 1976-02-10 1977-08-13 Kyowa Hakko Kogyo Co Ltd Preparation of powdery products
JPS52125615A (en) * 1976-04-09 1977-10-21 Kyowa Hakko Kogyo Co Ltd Method of making powdered products
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4521975A (en) * 1981-05-04 1985-06-11 Marquest Medical Products, Inc. Lyophilizing and forming biologicals having a predetermined unit dosage
FR2539626B2 (fr) * 1983-01-25 1985-06-21 Lafon Labor Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede

Also Published As

Publication number Publication date
JPS60224617A (ja) 1985-11-09
CA1233119A (en) 1988-02-23
ATE34078T1 (de) 1988-05-15
FR2561916B1 (fr) 1987-12-11
ZA852168B (en) 1985-11-27
FR2561916A1 (fr) 1985-10-04
EP0159237A1 (en) 1985-10-23
DE3562555D1 (en) 1988-06-16
AU567271B2 (en) 1987-11-12
AU4015385A (en) 1985-10-03
EP0159237B1 (en) 1988-05-11
JPH0581567B2 (es) 1993-11-15
US4616047A (en) 1986-10-07
ES8607011A1 (es) 1986-05-16

Similar Documents

Publication Publication Date Title
ES542483A0 (es) Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral
NO20005431D0 (no) Gelérbare farmasøytiske preparater
DE69521896D1 (de) Präparat auf lipidbasis, das diacylglyzerin, ein phospholipid, eine polare flüssigkeit und biologisch aktives material enthält
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
DK67783D0 (da) Pulverformig blanding omfattende amphifile lipidbestanddele og eventuelt hydrofobe bestanddele, fremgangsmade til fremstilling af samme, hydratiserede, lagdelte lipidfaser, fremgangsmade til fremstilling heraf samt kosmetisk sammensaetning
IT1216570B (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
KR960016908A (ko) 제약학상 담체
ES2063249T3 (es) Procedimiento para preparar composiciones de detergente de alta densidad aparente.
NO161674C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.
KR900701174A (ko) 인지질-함유 조성물, 이의 제조방법 및 이의 약제학적 물질용 부형제로서의 용도
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
SE8405754D0 (sv) 7-karboximetoxi-furo-(3,4-c)-pyridinderivat, framstellning derav och terapeutiska kompositioner innehallande dem
ES2042437T1 (es) Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.
HUP0002622A2 (hu) Nukleotid analógot tartalmazó, vérlemezke-aggregációs rendellenesség ellen hatásos gyógyszerkészítmények és eljárás előállításukra
NO20012011L (no) Fremstilling og anvendelse av stivnede oljer
PT84657A (en) Process for the fluidification by means of glycofurole of pharmaceutical compositions containing phosphatidylcholine for the introduction into soft gelatin capsules
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
SE8405118D0 (sv) 4-kloro-furo-(3,4-c)-pyridin-derivat forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
ZA987480B (en) Process for preparing contrast agents.
FR2769839B1 (fr) Composition anhydre a base de lactulose
JPS6161626A (ja) 乳化剤組成物の製造方法
SU1217415A1 (ru) Способ получени суппозиторной основы
KR920004414A (ko) 고순도의 결정성 펩티드 arg-lys-asp및 arg-lys-asp-val 및 이것들의 제조방법
JPS61137827A (ja) 安定なエラスタ−ゼ製剤
TH13284EX (th) กรรมวิธีแบบต่อเนื่องสำหรับผลิตวัสดุที่คล้ายครีมหรือสารเปียกแบบนอน-นิวโทเนียน

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050311